Top Markets
#1 0G 0G +24.46%
#2 SAFEcoin SAFEcoin +20.96%
#3 Axelar Axelar +20.82%
#4 Full Moon Full Moon +18.98%
#5 Zora Zora +17.42%
#6 AI XOVIA AI XOVIA +17.19%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.94%
#8 Cysic Cysic +16.30%
#9 VVS Finance VVS Finance +15.88%
#10 Apertum Apertum +13.94%
Coin of the day
0G 0G
설정
언어
한국어
통화
USD
테마
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
주식 순위 #12750
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
주가
$22.26
마지막 동기화: 2024-03-22
시가총액
$553.40M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Graphite Bio, Inc. (GRPH)

카테고리

Healthcare
Graphite Bio, Inc. (GRPH)의 주가 이력
최고 종가: $23.07 (2024-03-01 기준)

최저 종가: $174.18 (2021-06-01 기준)
Graphite Bio, Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2024 40.75%
2023 -26.18%
2022 -70.69%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH